Risankizumab
Risankizumab (BI 655066) is a humanized IgG monoclonal antibody (Kd <10 pM) targeting the IL-23 p19 subunit. It inhibits IL-17 production induced by human IL-23 in mouse splenocytes with an IC50 value of 2 pM. Risankizumab is used for the prevention and treatment of immune and inflammatory disorders such as psoriasis vulgaris, psoriatic arthritis, generalized pustular psoriasis, and erythrodermic psoriasis.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
IL Receptor
CAS Number
1612838-76-2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS7058408 Inquire
Recombinant Mycoplasma pneumoniae Uncharacterized protein MG384.1 homolog (MPN_565), partial
Ask
View Details MBS9319326-01 48 Well
Mouse Transmembrane emp24 domain-containing protein 1, TMED1 ELISA Kit
Ask
View Details 
MBS9319326-02 96 Well
Mouse Transmembrane emp24 domain-containing protein 1, TMED1 ELISA Kit
Ask
View Details MBS9319326-03 5x 96 Well
Mouse Transmembrane emp24 domain-containing protein 1, TMED1 ELISA Kit
Ask
View Details